At the genetic level, we characterize the genotype frequencies of CFHR3-CFHR1 in C3G patients and at the protein level, we assess circulating levels of FH, FHR-1, and FHR-5 in C3G patients as compared to disease-free controls and patients with other chronic kidney diseases (CKD). This evidence concerns the gene FH and chronic kidney disease.